{
    "2018-03-05": [
        [
            {
                "time": "2018-02-01",
                "original_text": "Bullish Two Hundred Day Moving Average Cross - NVS",
                "features": {
                    "keywords": [
                        "Bullish",
                        "Two Hundred Day Moving Average",
                        "Cross",
                        "NVS"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Here's Why Dermira Fell as Much as 64.2% Today",
                "features": {
                    "keywords": [
                        "Dermira",
                        "Fell",
                        "64.2%",
                        "Today"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Aduro (ADRO) Q4 Loss Narrower Than Expected, Revenues Miss",
                "features": {
                    "keywords": [
                        "Aduro",
                        "ADRO",
                        "Q4",
                        "Loss",
                        "Narrower",
                        "Revenues",
                        "Miss"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Noteworthy ETF Inflows: VEA, NSRGY, NVS, RDS.B",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflows",
                        "VEA",
                        "NSRGY",
                        "NVS",
                        "RDS.B"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "global equities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "What's in Store for Conatus (CNAT) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Conatus",
                        "CNAT",
                        "Earnings",
                        "Season"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Greek parliament set to probe politicians in alleged Novartis bribery case",
                "features": {
                    "keywords": [
                        "Greek",
                        "parliament",
                        "probe",
                        "politicians",
                        "Novartis",
                        "bribery",
                        "case"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Sanofi’s Valuations in February 2018",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Valuations",
                        "February 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Johnson & Johnson Stock: What’s behind the Recent Decline?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock",
                        "Recent",
                        "Decline"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "The Swiss Stock Market Staged A Strong Recovery",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Strong",
                        "Recovery"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "financial markets"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}